The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Graefe's Archive for Clinical and Experimental Ophthalmology

• Publication date

  2008-06-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00417-008-0865-9PMID 18546007
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lack of association of the VEGF gene promoter (−634 G→C and −460 C→T) polymorphism and the risk of advanced retinopathy of prematurity

  2007influential reference
• The Relationship of Retinal VEGF and Retinal IGF-1 mRNA with Neovascularization in an Acidosis-Induced Model of Retinopathy of Prematurity

  2006cited by this paper
• Genetic Susceptibility to Retinopathy of Prematurity

  2006cited by this paper
• Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy.

  2006cited by this paper
• Genetic Polymorphisms of Vascular Endothelial Growth Factor and Angiopoietin 2 in Retinopathy of Prematurity

  2006cited by this paper
• Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes.

  2005cited by this paper
• Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis.

  2005cited by this paper
• IGF-1 and Retinopathy of Prematurity in the Preterm Infant

  2005cited by this paper
• Association of Genetic Polymorphisms of Vascular Endothelial Growth Factor and Risk for Proliferative Retinopathy of Prematurity

  2005cited by this paper
• Retinopathy of prematurity and risk factors: a prospective cohort study

  2005cited by this paper
• Characteristics of Infants With Severe Retinopathy of Prematurity in Countries With Low, Moderate, and High Levels of Development: Implications for Screening Programs

  2005cited by this paper
• UK population based study of severe retinopathy of prematurity: screening, treatment, and outcome

  2005cited by this paper
• Genetic polymorphisms and retinopathy of prematurity.

  2004cited by this paper
• VEGFR-1: A Safe Target for Prophylaxis of Retinopathy of Prematurity?

  2004cited by this paper
• Variable oxygen and retinal VEGF levels: correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathy.

  2004cited by this paper
• Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.

  2004cited by this paper
• The role of VEGF and IGF-1 in a hypercarbic oxygen-induced retinopathy rat model of ROP.

  2004cited by this paper
• Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter.

  2003cited by this paper
• Retinopathy of prematurity in infants with birth weights greater than 1250 grams.

  2003cited by this paper
• Preliminary results of treatment of eyes with high-risk prethreshold retinopathy of prematurity in the early treatment for retinopathy of prematurity randomized trial.

  2003cited by this paper
• Implications of the natural course of retinopathy of prematurity.

  2003cited by this paper
• A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes.

  2002cited by this paper
• Retinopathy of prematurity: recent advances in our understanding

  2002cited by this paper
• Adult retinopathy of prematurity: outcomes of rhegmatogenous retinal detachments and retinal tears.

  2001cited by this paper
• A sudden rise in the prevalence of retinopathy of prematurity blindness?

  2001cited by this paper
• A Common 936 C/T Mutation in the Gene for Vascular Endothelial Growth Factor Is Associated with Vascular Endothelial Growth Factor Plasma Levels

  2000cited by this paper
• Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.

  2000cited by this paper
• Neonatal risk factors for retinopathy of prematurity--a population-based study.

  1998cited by this paper
• Racial Variation in Retinopathy of Prematurity

  1997cited by this paper
• Racial variation in retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.

  1997cited by this paper
• Localization of the human vascular endothelial growth factor gene,VEGF, at Chromosome 6p12

  1996cited by this paper
• Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.

  1996cited by this paper
• Susceptibility to retinopathy of prematurity in Alaskan Natives.

  1994cited by this paper
• Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.

  1993cited by this paper

• Analysis of Salivary Cytokines in Retinopathy of Prematurity

  2025cites this paper
• Retinopathy of Prematurity (ROP): An Overview of Biomarkers in Various Samples for Prediction, Diagnosis, and Prognosis

  2025cites this paper
• The association between VEGF genetic variations and the risk of bronchopulmonary dysplasia in premature infants: a meta-analysis and systematic review

  2024cites this paper
• Effect of Nasal Continuous Positive Airway Pressure on Retinopathy of Prematurity in Preterm Newborns: A Comparative Analysis with Mechanical Ventilation and High-Flow Nasal Cannula Therapy

  2024cites this paper
• Circulating VEGF-A Levels in Relation to Retinopathy of Prematurity and Treatment Effects: A Systematic Review and Meta-Analysis

  2024cites this paper
• Effectiveness of Propranolol in Preventing Severe Retinopathy of Prematurity: A Comprehensive Systematic Review and Meta-Analysis.

  2023cites this paper
• Systemic Cytokines in Retinopathy of Prematurity

  2023cites this paper
• Genetic Polymorphisms of Vascular Endothelial Growth Factor in Neonatal Pathologies: A Systematic Search and Narrative Synthesis of the Literature

  2023cites this paper
• Dysregulated genomic and coding-transcriptomic factors in retinopathy of prematurity

  2022cites this paper
• The Genetics of Disorders Affecting the Premature Newborn

  2022cites this paper
• Plasma Level of Apelin as a Promising Factor for Retinopathy of Prematurity

  2022cites this paper
• Effects of TIMP-2 Polymorphisms on Retinopathy of Prematurity Risk, Severity, Recurrence, and Treatment Response

  2022cites this paper
• Association between Retinopathy of Prematurity in Very-Low-Birth-Weight-Infants and Neurodevelopmental Impairment.

  2022cites this paper
• Optimization of diagnostics of retinopathy of prematurity stages based on the integration of clinical data using the Key to Diagnosis I software

  2022cites this paper
• Adenosine A2A receptor antagonism protects against hyperoxia‐induced retinal vascular loss via cellular proliferation

  2021cites this paper
• Tear Fluid Angiogenic Factors: Potential Noninvasive Biomarkers for Retinopathy of Prematurity Screening in Preterm Infants

  2021cites this paper
• Retinopathy of prematurity in Ardabil, North West of Iran: Prevalence and risk factors

  2021cites this paper
• Clinical outcome following reinjection of Ranibizumab for reactivation of retinopathy of prematurity

  2021cites this paper
• Effect of early exogenous supplementation of rhIGF-1 on oxygen-induced retinopathy in a mice model of prematurity, and on expressions of IGF-1 and VEGF

  2021cites this paper
• Association of -634 C/G Polymorphism at Vascular Endothelial Growth Factor Gene with Risk Retinopathy of Prematurity

  2020cites this paper
• Umbilical Blood Levels of IL-6 and TNF-α as Predictors of the Central Nervous System Damage and Retinopathy in Preterm Infants

  2020cites this paper
• Influence of polymorphisms in VEGF, TNF-α, and GSTP1 genes on retinopathy of prematurity risk: a Meta-analysis

  2020cites this paper
• Serum VEGF and Ang-2 Levels in Infants Before and After Laser Treatment for Retinopathy of Prematurity

  2020cites this paper
• EARLY VITAMIN A SUPPLEMENTATION IMPROVES THE OUTCOME OF RETINOPATHY OF PREMATURITY IN EXTREMELY PRETERM INFANTS

  2019cites this paper
• Vascular endothelial growth factor polymorphism rs2010963 status does not affect patent ductus arteriosus incidence or cyclooxygenase inhibitor treatment success in preterm infants

  2019cites this paper
• The value of VEGF and IGF-1 in the diagnosis retinopathy of prematurity and follow-up of response to laser therapy

  2019cites this paper
• Prematür retinopatisinin tanısı ve lazer tedavisine cevabın takibinde VEGF ve IGF-1’in değeri

  2019cites this paper
• An Updated and Comprehensive Meta-Analysis of Association between VEGA -634G > C, -460T > C, +405G > C and +936C > T Polymorphisms and Retinopathy of Prematurity Risk

  2019cites this paper
• The genetics of retinopathy of prematurity: a model for neovascular retinal disease.

  2018cites this paper
• Retinopathy of prematurity: a review of risk factors and their clinical significance.

  2018cites this paper
• The progress of prophylactic treatment in retinopathy of prematurity.

  2018cites this paper
• A Pathogenic Relationship of Bronchopulmonary Dysplasia and Retinopathy of Prematurity? A Review of Angiogenic Mediators in Both Diseases

  2018cites this paper
• Comparison of Bevacizumab and Ranibizumab in the Treatment of Type 1 Retinopathy of Prematurity Affecting Zone 1

  2018cites this paper
• Elimination of Signaling by the Luteinizing Hormone Receptor Reduces Ocular VEGF and Retinal Vascularization during Mouse Eye Development

  2018cites this paper
• Efficacy of intravitreal aflibercept monotherapy in retinopathy of prematurity evaluated by periodic fluorescence angiography and optical coherence tomography

  2018cites this paper
• Stage 5 retinopathy of prematurity: An update

  2018cites this paper
• Effect of Intravitreal Aflibercept on Central Retinal Arterial Blood Flow in Type 1 Retinopathy of Prematurity

  2017cites this paper
• The Effects of Preterm Birth on Visual Function in Childhood

  2017influential citation
• Relationship between the 5'UTR of vascular endothelial growth factor polymorphism and retinopathy of prematurity in Chinese premature newborns.

  2017cites this paper
• The association between systemic vascular endothelial growth factor and retinopathy of prematurity in premature infants: a systematic review

  2016cites this paper
• Association between VEGF polymorphisms (−460 T/C and +936 C/T) and retinopathy of prematurity risk: A meta-analysis

  2016cites this paper
• Investigation of TNF-alpha gene (G308A) and GSTP1 gene (Ilel05Val) polymorphisms in Turkish patients with retinopathy of prematurity.

  2015cites this paper
• Polymorphisms of Vascular Endothelial Growth Factor and Retinopathy of Prematurity.

  2015cites this paper
• Effect of laser photocoagulation on plasma levels of VEGF-A, VEGFR-2, and Tie2 in infants with retinopathy of prematurity.

  2014cites this paper
• Structural, Visual and Refractive Outcomes of Intravitreal Aflibercept Injection in High-Risk Prethreshold Type 1 Retinopathy of Prematurity

  2014cites this paper
• Retinopatía de la prematuridad. ¿Qué debe saber el pediatra?

  2014cites this paper
• Vascular endothelial growth factor (VEGF-634G/C) polymorphism and retinopathy of prematurity: a meta-analysis.

  2014cites this paper
• Genetic polymorphisms of vascular endothelial growth factor and risk for retinopathy of prematurity in South of Iran

  2013cites this paper
• Associations of VEGF/VEGF-Receptor and HGF/c-Met Promoter Polymorphisms With Progression/Regression of Retinopathy of Prematurity

  2013cites this paper
• APELIN IN EPIRETINAL FIBROVASCULAR MEMBRANES OF PATIENTS WITH RETINOPATHY OF PREMATURITY AND THE CHANGES AFTER INTRAVITREAL BEVACIZUMAB

  2013influential citation
• Serum erythropoietin, insulin-like growth factor 1, and vascular endothelial growth factor in etiopathogenesis of retinopathy of prematurity.

  2013cites this paper
• Chapter 26 – Basic Mechanisms of Pathological Retinal and Choroidal Angiogenesis

  2013cites this paper
• Association of VEGF gene polymorphisms with advanced retinopathy of prematurity: a meta-analysis

  2012cites this paper
• Meta analysis on the relationship between gene polymorphisms of vascular endothelial growth factor and retinal prognosis risk of prematurity.

  2012cites this paper
• Rescue Intravitreal Bevacizumab (Avastin) for Aggressive Posterior Retinopathy of Prematurity

  2011cites this paper
• Genetic variation of vascular endothelial growth factor pathway does not correlate with the severity of retinopathy of prematurity

  2011cites this paper
• VAISIAUS UŽDEGIMINIS ATSAKAS IR POKYČIAI PLACENTOJE

  2011cites this paper
• VEGF 936C>T is predictive of threshold retinopathy of prematurity in Japanese infants with a 30-week gestational age or less

  2011influential citation
• Adopting Western Retinopathy of Prematurity Screening Programs in Eastern Countries, are we Screening Properly?

  2011cites this paper
• Genetic susceptibility to advanced retinopathy of prematurity (ROP)

  2010cites this paper
• Lack of association of genetic polymorphisms of angiotensin-converting enzyme gene I/D and glutathione-S-transferase enzyme T1 and M1 with retinopathy of prematures.

  2010cites this paper
• Antivascular endothelial growth factor for retinopathy of prematurity

  2009cites this paper
• Brain-Derived Neurotrophic Factor in Infants <32 Weeks Gestational Age: Correlation With Antenatal Factors and Postnatal Outcomes

  2009cites this paper